ArticleScientific reports2026
Natural genetic variation impacts complement inhibitory activity of PFam54 orthologs of Asian Borrelia bavariensis.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
European and Asian populations of Borrelia (B.) bavariensis, a causative agent of Lyme borreliosis, substantially differ in their infection dynamics. This is argued to be a byproduct of the unique demographic history of B. bavariensis in relation to colonizing Europe from a highly diverse, ancestral Asian population. Whether genetic factors related to human disease could be unique traits associated with the demographic history of the European population though remains largely unclear. European B. bavariensis possesses at least two anti-complement determinants, BGA66 and BGA71 encoding by genes of the PFam54 gene array. In Asian B. bavariensis populations, the composition of this gene array is highly diverse. To assess functional integrity of PFam54 orthologs, two Asian B. bavariensis isolates, NT24 and JHM1114, were investigated. Despite the substantial observed genetic diversity, the complement-inhibitory and cell-protective function of BGA66 and BGA71 orthologs are largely conserved among European and Asian populations. We also identified two novel PFam54 orthologs of Asian origin, BGA67b and BGA71b, both of which display anti-complement activity on the terminal pathway and confer serum resistance. Taken together, our findings highlight the importance of studying natural variation of proteins potentially involved in immune escape, pathogenesis, and host adaptation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.